Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical
Follow on Google News
Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical/BS
Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical
India’s Sun Pharmaceutical Industries Ltd has revealed plans to acquire the remaining outstanding shares of Taro Pharmaceutical Industries Ltd. Valued at approximately 2,891 crore Indian Rupees, this strategic move is expected to strengthen Sun Pharma’s global position.
The acquisition, subject to regulatory approvals, is anticipated to enhance operational efficiency and contribute to long-term growth.
The deal is set to close in the first half of 2024, leading to Taro becoming a privately held company.
Latest Posts
- US believes Iran hasn’t decided to build a nuclear weapon
October 11, 2024 | Breaking News, United States of America, World - Big Win for MH370 Families: Chinese Court Awards ₹4 Crore Each from Malaysia Airlines
December 9, 2025 | Breaking News, World - Lok Sabha To Take Up Electoral Reforms Today, 10-Hour Debate Scheduled
December 9, 2025 | Breaking News - Best Cheap Destinations To Escape The Harsh Winter
December 8, 2025 | Featured Edition - Amid Flight Disruptions, IndiGo Shares Drop Over 6.5%
December 8, 2025 | Breaking News, Business, India - 25 Dead As Massive Fire Guts Popular Goa Nightclub; Manager Arrested, Hunt On For Owner
December 7, 2025 | Breaking News, India - Donald Trump Receives First FIFA Peace Prize: What It Is
December 7, 2025 | Breaking News, Politics, World - J-K LG Manoj Sinha vs Omar Abdullah Over Age Relaxation For Job Aspirants
December 6, 2025 | Breaking News, Jammu Kashmir, Politics - Realme Narzo Phones Confirmed to Launch in India Soon via Amazon
December 6, 2025 | Breaking News, Tech - Nothing Phone 3a Lite Goes on Sale in India: See Price, Offers, Availability
December 6, 2025 | Tech - NVIDIA Needed Just $2200 to Make Investors Millionaires
December 6, 2025 | Business, World